Atlantic Coastal Acquisition Corp. II (ACAB) Financial Statements (2025 and earlier)

Company Profile

Business Address 6 ST JOHNS LANE, FLOOR 5
NEW YORK, NY 10013
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments237112659482,228295
Cash and cash equivalents237112659482,228295
Prepaid expense4115 106218277
Asset, held-in-trust  29,729   
Other undisclosed current assets      
Total current assets:2772629,9941,0542,445572
Noncurrent Assets
Asset, held-in-trust7,6197,5087,37236,46635,998313,075
Total noncurrent assets:7,6197,5087,37236,46635,998313,075
TOTAL ASSETS:7,8967,53437,36637,52038,443313,647
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,5161,3614697151,7961,579
Accrued liabilities3393124697151,7961,579
Other undisclosed accounts payable and accrued liabilities1,1771,048    
Financial instruments subject to mandatory redemption, settlement terms, share value, amount   29,729   
Other liabilities      
Other undisclosed current liabilities5,7915,2445,1904,7944,5911,579
Total current liabilities:7,3066,60535,3885,5096,3873,158
Noncurrent Liabilities
Liabilities, other than long-term debt 10,50010,50010,50010,50010,50010,500
Deferred compensation liability, classified 10,50010,50010,50010,50010,50010,500
Other undisclosed noncurrent liabilities  0   
Total noncurrent liabilities:10,50010,50010,50010,50010,50010,500
Total liabilities:17,80617,10545,88816,00916,88713,658
Temporary equity, carrying amount7,4877,4147,29336,56936,362311,652
Equity
Equity, attributable to parent, including:(17,397)(16,985)(15,815)(15,058)(14,806)(11,663)
Accumulated deficit(17,398)(16,986)(15,816)(15,059)(14,807)(11,664)
Other undisclosed equity, attributable to parent111111
Other undisclosed equity   (0)   
Total equity:(17,397)(16,985)(15,815)(15,058)(14,806)(11,663)
TOTAL LIABILITIES AND EQUITY:7,8967,53437,36637,52038,443313,647

Income Statement (P&L) ($ in thousands)

9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
Revenues
(Net Investment Income)
      
Gross profit:      
Operating expenses      
Other undisclosed operating loss(394)(1,141)(393)(315)(420)(538)
Operating loss:(394)(1,141)(393)(315)(420)(538)
Nonoperating income81964693671,5413,288
Income (loss) from continuing operations before income taxes:(313)(1,045)77511,1202,751
Income tax expense(26)(4)(84)(96)(318)(680)
Net income (loss) attributable to parent:(339)(1,049)(7)(45)8032,071
Preferred stock dividends and other adjustments      
Other undisclosed net income available to common stockholders, basic   29,729   
Net income (loss) available to common stockholders, diluted:(339)(1,049)29,722(45)8032,071

Comprehensive Income ($ in thousands)

9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
Net income (loss):(339)(1,049)(7)(45)8032,071
Comprehensive income (loss), net of tax, attributable to parent:(339)(1,049)(7)(45)8032,071

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: